Motti Hakim

Motti Hakim is experienced in leading R&D efforts in the biologics industry, focusing on immune-oncology agents and immunomodulatory biologics for cancer therapy. With a background in structural biology, Motti has managed teams and subcontractors in various companies to develop novel therapies and platforms for drug specificity evaluation.